Expand NRIX Menu
NRIX MENU

NRIX Latest Press Releases

-- April 8, 2026 --

Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update Globe Newswire 6:00 AM

-- April 7, 2026 --

Nurix Therapeutics to Participate in Upcoming Investor Conference Globe Newswire 7:00 AM

-- March 23, 2026 --

Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting Globe Newswire 4:05 PM

-- January 28, 2026 --

Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update Globe Newswire 4:01 PM

-- January 12, 2026 --

Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases Globe Newswire 7:00 AM

-- January 5, 2026 --

Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 7:00 AM

-- December 24, 2025 --

Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge Globe Newswire 6:00 AM

-- December 8, 2025 --

Nurix Therapeutics Presents New Data from the Phase 1 Trial of Bexobrutideg (NX-5948) in Waldenstrm Macroglobulinemia at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition Globe Newswire 8:00 AM

-- December 6, 2025 --

Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition Globe Newswire 9:30 AM

-- December 1, 2025 --

Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition Globe Newswire 7:00 AM

-- November 25, 2025 --

Nurix Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes